Synthase Biotech Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Out of Business

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Out of Business

Synthase Biotech General Information

Description

Developer of a plant-based enzyme designed to deliver effective preventative treatments for lipid peroxidation. The company's enzyme focuses on biopreservation, life extension, and increasing animal fertility by blocking the pathway of damage caused by lipid oxidation, maintaining and restoring cellular function, health, and vitality, enabling cattle breeders to improve the ability of their cows to conceive.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Ruakura Research Centre
  • Private Bag 3123
  • Hamilton, 3123
  • New Zealand
Primary Industry
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • Ruakura Research Centre
  • Private Bag 3123
  • Hamilton, 3123
  • New Zealand

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Synthase Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Out of Business 24-Oct-2025 Completed Out of Business
7. Later Stage VC Completed Generating Revenue
6. Later Stage VC 01-Aug-2022 Cancelled Generating Revenue
5. Grant 01-Oct-2020 Completed Generating Revenue
4. Later Stage VC 01-Sep-2020 Cancelled Generating Revenue
3. Later Stage VC 01-Dec-2019 Completed Generating Revenue
2. Later Stage VC (Series C) 01-Dec-2018 $6.4M $7.2M Completed Generating Revenue
1. Seed Round 05-Dec-2016 $800K $800K Completed Generating Revenue
To view Synthase Biotech’s complete valuation and funding history, request access »

Synthase Biotech Patents

Synthase Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025116748-A1 Novel compositions and uses Inactive 30-Nov-2023
CA-3208144-A1 Enhanced birth rates Pending 11-Feb-2021
EP-4291027-A1 Enhanced birth rates Inactive 11-Feb-2021
EP-4291027-A4 Enhanced birth rates Inactive 11-Feb-2021
WO-2022173313-A1 Enhanced birth rates Inactive 11-Feb-2021 A61P15/08
To view Synthase Biotech’s complete patent history, request access »

Synthase Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Synthase Biotech FAQs

  • When was Synthase Biotech founded?

    Synthase Biotech was founded in 2015.

  • Where is Synthase Biotech headquartered?

    Synthase Biotech is headquartered in Hamilton, New Zealand.

  • What is the size of Synthase Biotech?

    Synthase Biotech has 3 total employees.

  • What industry is Synthase Biotech in?

    Synthase Biotech’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Synthase Biotech a private or public company?

    Synthase Biotech is a Private company.

  • What is Synthase Biotech’s current revenue?

    The current revenue for Synthase Biotech is .

  • How much funding has Synthase Biotech raised over time?

    Synthase Biotech has raised $8.32M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process